Consecutively, the combination of exosomal miR-620 with CEA or CYFRA21-1 showed a significant improvement in the diagnostic ability of early-stage NSCLC (AUC = 0.814 and 0.761, respectively) (Figures 3(f) and 3(g)). This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.